(Q41155439)

27 September 2017

title

Statistical modelling in analysis of prognosis in glioblastoma multiforme: a study of clinical variables and Ki-67 index (English)

1 reference

27 September 2017

0 references

1 reference

0 references

Pigott TJ

1

1 reference

27 September 2017

Lowe JS

series ordinal

2

1 reference

27 September 2017

Palmer J

series ordinal

3

1 reference

27 September 2017

publication date

1 January 1991

1 reference

British Journal of Neurosurgery

27 September 2017

published in

1 reference

27 September 2017

volume

5

1 reference

27 September 2017

issue

1

1 reference

27 September 2017

page(s)

61-66

1 reference

Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.

27 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Patient age, histologic features, and length of survival in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Cell kinetics of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Prognostic implications of the bromodeoxyuridine labeling index of human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Survival in glioblastoma: historical perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

The relative significance of factors affecting postoperative survival in astrocytomas, grades 3 and 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Histologic and non-histologic factors correlated with survival time in supratentorial astrocytic tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02688699108998448

Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma—Final evaluation

21 January 2018

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/0014-2964(78)90100-7

Identifiers

DOI

10.3109/02688699108998448

1 reference

27 September 2017

1 reference